Skip to main content

Search

By Susan Morse | 11:24 am | April 03, 2026
Exemptions include generic drugs and companies that have committed to building manufacturing plants in the United States.
By Susan Morse | 11:16 am | March 25, 2026
FTC reached a settlement with Express Scripts in February and is currently in negotiations with OptumRx.
By Susan Morse | 11:09 am | March 18, 2026
Preliminary injunction also stays the appointment of 13 members of ACIP and halts all votes taken by the committee.
By Susan Morse | 10:51 am | February 27, 2026
CarepathRx supports a range of home and ambulatory infusion solutions to hospitals and health systems, Evernorth says.
By Susan Morse | 10:15 am | February 26, 2026
Eliminating seven childhood vaccines from their recommended status will make children sicker and strain state resources, court documents say.
By Susan Morse | 11:04 am | February 22, 2026
Physicians tell Dr. Amy Bucher they feel a sense of empowerment in being able to offer their patients something that, along with lifestyle changes, reduces weight, lowers the risk of diabetes and high blood pressure, and helps prevent other chronic conditions.
By Susan Morse | 11:02 am | February 09, 2026
HHS could potentially restart the administrative process for such a program.
By Susan Morse | 11:22 am | February 04, 2026
The minibus package also funds HHS and extends acute hospital care at home.
By Susan Morse | 05:14 pm | January 25, 2026
Ferrin Williams, PharmD MBA, chief pharmacy officer at Scripta Insights, gives insights in this Q&A.
By Susan Morse | 11:25 am | January 23, 2026
Bill would prohibit PBM compensation in Medicare Part D from being tied to the manufacturer’s list price of a drug.